Literature DB >> 8611178

Age-related changes in the content of the C-terminal region of aggrecan in human articular cartilage.

J Dudhia1, C M Davidson, T M Wells, D H Vynios, T E Hardingham, M T Bayliss.   

Abstract

The content of the C-terminal region of aggrecan was investigated in samples of articular cartilage from individuals ranging in age from newborn to 65 years. This region contains the globular G3 domain which is known to be removed from aggrecan in mature cartilage, probably by proteolytic cleavage, but the age-related changes in its abundance in human cartilage have not been described previously. The analysis was performed by immunosorbant assay using an antiserum (JD5) against recombinant amino acid residues of human aggrecan, on crude extracts of cartilage without further purification of aggrecan. The results showed that the content of the C-terminal region decreased with age relative to the G1 domain content (correlation coefficient = 0.463). This represented a 92% fall in the content of this region of the molecule from newborn to 65 years of age. furthermore, when the G1 content of the cartilage extracts was corrected to only include the G1 attached to aggrecan and to exclude the G1 fragments which accumulate as a by-product of normal aggrecan turnover (free G1), the age-related decrease in the C-terminal region remained very pronounced. Analysis by composite agarose/PAGE showed that the number of subpopulations of aggrecan resolved increased from one in newborn to three in adult cartilage. All of these reacted with an antiserum to the human G1 domain, but only the slowest migrating species reacted with the C-terminal region antiserum (JD5). Similar analysis by SDS/PAGE confirmed the presence of high-molecular-mass (200 kDa) proteins reactive with JD5, but no reactive fragments of lower electrophoretic mobility were detected. In contrast, when probed with the antiserum to the human G1 domain, the immunoblots showed protein species corresponding to the free G1 and G1-G2 fragments, which were present at high concentrations in adult cartilage. The results suggest that the loss of the C-terminal region is not directly part of the process of aggrecan turnover, but it is a slow independent matrix process that occurs more extensively with aging as turnover rates become slower. Young cartilage with the fastest turnover contains least molecules lacking the C-terminal region, whereas in old tissue with slow turnover few molecules retain this region. An increase in the cleavage of this region with age may also contribute to this change. The content of the C-terminal region may thus give a measure of the abundance of newly synthesized aggrecan.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611178      PMCID: PMC1217001          DOI: 10.1042/bj3130933

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

Review 1.  Leukocyte-endothelial cell interactions.

Authors:  R P McEver
Journal:  Curr Opin Cell Biol       Date:  1992-10       Impact factor: 8.382

2.  Expression and characterization of a carbohydrate-binding fragment of rat aggrecan.

Authors:  S Saleque; N Ruiz; K Drickamer
Journal:  Glycobiology       Date:  1993-04       Impact factor: 4.313

3.  Expression of alternatively spliced epidermal growth factor-like domains in aggrecans of different species. Evidence for a novel module.

Authors:  C Fülöp; E Walcz; M Valyon; T T Glant
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

4.  Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family.

Authors:  H Yamada; K Watanabe; M Shimonaka; Y Yamaguchi
Journal:  J Biol Chem       Date:  1994-04-01       Impact factor: 5.157

5.  A cartilage explant system for studies on aggrecan structure, biosynthesis and catabolism in discrete zones of the mammalian growth plate.

Authors:  A H Plaas; J D Sandy
Journal:  Matrix       Date:  1993-03

6.  The epidermal growth factor-like domain of the human cartilage large aggregating proteoglycan, aggrecan: increased serum concentration in rheumatoid arthritis.

Authors:  H J Møller; T Ingemann-Hansen; J H Poulsen
Journal:  Br J Rheumatol       Date:  1994-01

7.  The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B.

Authors:  A J Fosang; P J Neame; K Last; T E Hardingham; G Murphy; J A Hamilton
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

8.  Biotinylated hyaluronic acid as a probe for identifying hyaluronic acid-binding proteins.

Authors:  B Yang; B L Yang; P F Goetinck
Journal:  Anal Biochem       Date:  1995-07-01       Impact factor: 3.365

Review 9.  The cartilage proteoglycan aggregate: assembly through combined protein-carbohydrate and protein-protein interactions.

Authors:  M Mörgelin; D Heinegård; J Engel; M Paulsson
Journal:  Biophys Chem       Date:  1994-05       Impact factor: 2.352

10.  Nanomelic chondrocytes synthesize, but fail to translocate, a truncated aggrecan precursor.

Authors:  B M Vertel; L M Walters; B Grier; N Maine; P F Goetinck
Journal:  J Cell Sci       Date:  1993-03       Impact factor: 5.285

View more
  24 in total

1.  Mature bovine articular cartilage contains abundant aggrecan that is C-terminally truncated at Ala719-Ala720, a site which is readily cleaved by m-calpain.

Authors:  Hidefumi Oshita; John D Sandy; Kiichi Suzuki; Atsushi Akaike; Yun Bai; Tomohiro Sasaki; Katsuji Shimizu
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

2.  Assessment of the clinical significance of gelatinase activity in patients with juvenile idiopathic arthritis using quantitative protein substrate zymography.

Authors:  N J Peake; H E Foster; K Khawaja; T E Cawston; A D Rowan
Journal:  Ann Rheum Dis       Date:  2005-09-08       Impact factor: 19.103

3.  The intermediates of aggrecanase-dependent cleavage of aggrecan in rat chondrosarcoma cells treated with interleukin-1.

Authors:  J D Sandy; V Thompson; K Doege; C Verscharen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

4.  Conserved basic residues in the C-type lectin and short complement repeat domains of the G3 region of proteoglycans.

Authors:  N C Brissett; S J Perkins
Journal:  Biochem J       Date:  1998-01-15       Impact factor: 3.857

5.  Phenotypic diversity of neoplastic chondrocytes and extracellular matrix gene expression in cartilaginous neoplasms.

Authors:  T Aigner; S Dertinger; S I Vornehm; J Dudhia; K von der Mark; T Kirchner
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

6.  Age-related changes in the structure of the keratan sulphate chains attached to fibromodulin isolated from articular cartilage.

Authors:  R M Lauder; T N Huckerby; I A Nieduszynski; A H Plaas
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

7.  Age-related nanostructural and nanomechanical changes of individual human cartilage aggrecan monomers and their glycosaminoglycan side chains.

Authors:  Hsu-Yi Lee; Lin Han; Peter J Roughley; Alan J Grodzinsky; Christine Ortiz
Journal:  J Struct Biol       Date:  2012-12-25       Impact factor: 2.867

8.  Age-related changes in the composition, the molecular stoichiometry and the stability of proteoglycan aggregates extracted from human articular cartilage.

Authors:  Terri Wells; Catherine Davidson; Matthias Mörgelin; Joseph L E Bird; Michael T Bayliss; Jayesh Dudhia
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

9.  Proteoglycans and catabolic products of proteoglycans present in ligament.

Authors:  Mirna Z Ilic; Phillip Carter; Alicia Tyndall; Jayesh Dudhia; Christopher J Handley
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

10.  Age-related changes in the synthesis of link protein and aggrecan in human articular cartilage: implications for aggregate stability.

Authors:  M C Bolton; J Dudhia; M T Bayliss
Journal:  Biochem J       Date:  1999-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.